Related Experiment Video
Updated: Jan 22, 2026
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.6K
Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement
Wenrui Ma1,2, Yan Tan3, Qiuxia Shi4
1Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai, China.
The Thoracic and Cardiovascular Surgeon
|June 29, 2019
Summary
Continuous beta-blocker (BB) therapy after bioprosthetic mitral valve replacement significantly delays structural valve deterioration (SVD). This therapy improves prosthetic durability without impacting cardiac mortality, offering a potential strategy for better long-term outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
- Clinical Medicine
Background:
- Structural valve deterioration (SVD) is a primary limitation of bioprosthetic heart valves.
- Optimizing long-term outcomes after mitral valve replacement is crucial.
Purpose of the Study:
- To investigate the impact of continuous beta-blocker (BB) therapy on SVD after bioprosthetic mitral valve replacement.
- To assess the effect of BB therapy on prosthetic durability and cardiac mortality.
Main Methods:
- A retrospective study involving 138 patients undergoing bioprosthetic mitral valve replacement between 2000 and 2005.
- Propensity score matching in a 1:1 ratio for patients with (n=69) and without (n=69) continuous BB therapy.
- Median follow-up of 12.3 years to evaluate SVD and cardiac mortality.
Main Results:
- Continuous BB therapy was associated with a significantly higher 10-year freedom from SVD (92.4% vs. 76.3%, p=0.001).
- Cardiac mortality rates were comparable between the BB therapy group and the no-BB therapy group (p=0.13).
Conclusions:
- Continuous beta-blocker therapy may be a beneficial strategy to delay SVD after bioprosthetic mitral valve replacement.
- BB therapy has the potential to enhance the durability of bioprosthetic mitral valves.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
924
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
924
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
194
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
194
01:27Mitral Valve Prolapse I: Introduction
416
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
416
01:22Mitral Valve Prolapse II: Assessment and Management
472
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
472
01:19Mitral Valve Prolapse III: Nursing Management
314
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
314
01:13Mortar Joint Deterioration in Masonry
339
Mortar joint deterioration is a significant concern in masonry structures, with water accumulation in the joints leading to damage from freeze-thaw cycles. The repeated expansion of water during freezing and its melting during thawing develop and propagate cracks in the masonry joints. Eventually, this leads to the spalling of mortar from the joints, loosening masonry units and weakening the structure. The deteriorated mortar joints are also vulnerable to moisture intrusion into the walls.
The...
The...
339